Molecular tumor profiling is becoming a routine part of clinical cancer care, typically involving tumor-only panel testing without matched germline. We hypothesized that integrated germline sequencing ...
Current National Comprehensive Cancer Network (NCCN) guidelines for germline testing are complex and often miss patients with cancer susceptibility. We evaluated results of universal germline genetic ...
Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine. Some leading organizations in the field of cell and gene therapies recently issued a call for a 10-year ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results